This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

OMEGA LABORATORIES LIMITED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of THIAMIJECT INJECTION - LIQ IM IV 100MG/ML in Canada?

Yes. THIAMIJECT INJECTION - LIQ IM IV 100MG/ML has an active shortage reported to Health Canada (last updated August 5, 2026).

Why is THIAMIJECT INJECTION - LIQ IM IV 100MG/ML not available?

The reason the manufacturer reported: Demand increase for the drug.

When will THIAMIJECT INJECTION - LIQ IM IV 100MG/ML be available again?

The manufacturer's estimated resolution date is December 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength100MG

Last updated2026-07-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02193221

Strength

100MG

Dosage Form

LIQUID

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

THIAMINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-07-13

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

THIAMIJECT INJECTION - LIQ IM IV 100MG/ML has 2 shortage/discontinuation reports on file — this is one of them.

2026-08-05

Active Shortage

Demand increase for the drug.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413